Vanguard Group Inc Vanda Pharmaceuticals Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,631,289 shares of VNDA stock, worth $17.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,631,289

Previous 3,431,671 5.82%

Holding current value

$17.4 Million

Previous $19.4 Million 12.16%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.61 - $6.34 $920,238 - $1.27 Million	199,618 Added 5.82%	3,631,289 $17 Million
Q2 2024 Aug 13, 2024	BUY	$3.91 - $6.5 $141,104 - $234,572	36,088 Added 1.06%	3,431,671 $19.4 Million
Q1 2024 May 10, 2024	SELL	$3.47 - $4.61 $209,948 - $278,923	-60,504 Reduced 1.75%	3,395,583 $14 Million
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $64,912 - $87,958	-19,205 Reduced 0.55%	3,456,087 $14.6 Million
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $3.26 Million - $5.01 Million	-762,144 Reduced 17.99%	3,475,292 $15 Million
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $644,999 - $759,787	109,322 Added 2.65%	4,237,436 $27.9 Million
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $840,158 - $1.09 Million	135,948 Added 3.41%	4,128,114 $28 Million
Q4 2022 Feb 10, 2023	BUY	$6.87 - $10.96 $670,594 - $1.07 Million	97,612 Added 2.51%	3,992,166 $29.5 Million
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $536,399 - $668,226	56,822 Added 1.48%	3,894,554 $38.5 Million
Q2 2022 Aug 12, 2022	BUY	$9.31 - $11.84 $576,205 - $732,789	61,891 Added 1.64%	3,837,732 $41.8 Million
Q1 2022 May 13, 2022	SELL	$10.84 - $16.55 $1.09 Million - $1.67 Million	-100,843 Reduced 2.6%	3,775,841 $42.7 Million
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $1.72 Million - $2.31 Million	-109,444 Reduced 2.75%	3,876,684 $60.8 Million
Q3 2021 Nov 12, 2021	SELL	$15.35 - $21.27 $1.69 Million - $2.34 Million	-109,950 Reduced 2.68%	3,986,128 $68.3 Million
Q2 2021 Aug 13, 2021	BUY	$15.71 - $21.51 $64.3 Million - $88.1 Million	4,096,078 New	4,096,078 $88.1 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $270M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Vanda Pharmaceuticals Inc. Transaction History